ELV
Elevance Health Inc.NYSEHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
11.72
PEG
—
P/B
1.52
P/S
0.33
EV/EBITDA
9.33
DCF Value
$1,503.82
FCF Yield
4.8%
Div Yield
2.3%
Margins & Returns
Gross Margin
25.6%
Operating Margin
4.1%
Net Margin
2.8%
ROE
13.0%
ROA
6.9%
ROIC
6.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $49.75B | $547.0M | $2.47 |
| FY 2025 | $199.13B | $5.66B | $25.12 |
| Q3 2025 | $50.71B | $1.19B | $5.32 |
| Q2 2025 | $49.78B | $1.74B | $7.72 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
0.50
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.